19 March 2024

Volunteer patients required for Optometry Tomorrow 2024

Contact lenses Glaucoma

Patients will be paid £25 per session and all travel expenses will be reimbursed.

We are looking for volunteer patients to take part in clinical workshops at Optometry Tomorrow 2024, now incorporating BCLA focus. The conference will take place on 28-29 April 2024 at The Telford International Centre. 

Volunteers will receive a £25 fee per one hour session and travel expenses will be refunded. These practical sessions are designed to help enhance optometrists' skills.

Patients with one or more of the following conditions can apply:

  • keratoconus
  • keratoconus patients who are existing RGP corneal lens wearers
  • concomitant squint (eg childhood eso/exotropia)
  • angle closure
  • a congential incomitancy (eg Duanes/Browns)
  • an acquired incomitancy
  • anterior eye pathology
  • lid malposition, punctal stenosis, epiphora, ectropion, entropion, known nasolacrimal duct obstruction
  • glaucoma.

How to apply

Please contact Emily Rowbotham on 020 7766 4388 or emily.rowbotham@college-optometrists.org

Related news

Nominations open for Research Excellence Awards 2024
Research

The DWP Personal Independence Payments (PIP) conditions list and how it’s used

The College and RAC welcome Government decision to commission independent study into headlight glare
Driving and vision

Related further reading

Vision Made Possible

ADVERTISEMENT: Kate Stockwell, Head of Marketing – Vision Care at Johnson & Johnson explains the company’s commitment to creating a world where vision is made possible for everyone.

Cataract Contact lenses

A colleague is not performing dilated examinations when it's clinically required. What do you do?

In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.

AMD Glaucoma Medical retina

Plan beta?

Pressure on optometrists to treat glaucoma is likely to grow as case numbers are predicted to rise 44% by 2035. Beta blockers will remain a part of the fight ahead, as Adrian O’Dowd reports.

Glaucoma